<amendment session="115" chamber="h" number="113" updated="2017-06-24T04:42:30Z">
  <amends type="h" number="1694" sequence=""/>
  <status datetime="2017-04-27T14:43:41-04:00">pass</status>
  <sponsor bioguide_id="C001049"/>
  <offered datetime="2017-04-27"/>
  <description>An amendment numbered 3 printed in Part B of House Report 115-96 to clarify that nothing in the bill may be construed to preclude or restrict disclosure of information regarding new products or significant new product terms prior to loan purchasing.</description>
  <actions>
    <vote datetime="2017-04-27T14:43:41-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Clay amendment Agreed to by voice vote.</text>
    </vote>
    <action datetime="2017-04-27T14:40:31-04:00">
      <text>Amendment (A003) offered by Mr. Clay.</text>
      <reference ref="CR H2922-2923" label="consideration"/>
      <reference ref="CR H2922-2923" label="text"/>
    </action>
    <action datetime="2017-04-27"/>
    <action datetime="2017-04-27T14:43:41-04:00">
      <text>Amendment agreed to Committee of the Whole</text>
    </action>
    <action datetime="2017-04-27T14:43:41-04:00">
      <text>House amendment agreed to: On agreeing to the Clay amendment Agreed to by voice vote.</text>
    </action>
    <action datetime="2017-04-27T14:40:31-04:00">
      <text>House amendment offered/reported by : Amendment (A003) offered by Mr. Clay.</text>
    </action>
    <action datetime="2017-04-27">
      <text>House amendment offered</text>
    </action>
  </actions>
</amendment>
